
Topicals are among the most exciting product categories in the broader cannabis and hemp universe, as they offer an entirely different approach to the plant compared to flowers, oils, or inhalation methods. We are referring to externally applicable products such as creams, balms, salves, lotions, or nourishing oils that contain cannabinoid or hemp-based ingredients and are applied directly to the skin. Particularly in the CBD sector, this has developed into a rapidly growing segment over the last few years, sitting somewhere between cosmetics, regeneration, and wellness. At the same time, the topic is significantly more complex than many product descriptions would have you believe: not every "cannabis topical" is automatically a highly effective skin product, not every CBD topical can be categorized the same way legally, and not every advertising claim is scientifically supported.
For Cannaseuse, the subject is especially interesting because topicals lie exactly at the intersection of plant knowledge, cannabinoid expertise, and modern product culture. They demonstrate that hemp should not only be viewed in terms of seeds, flowers, or cannabinoid profiles, but also through the lens of skin, textures, cosmetic formulations, and everyday use. In a curated environment, this is a powerful encyclopedic topic because technical knowledge is more important here than mere beauty marketing.
Topicals are externally applicable formulations intended to remain on or be absorbed by the skin. In the cannabis and CBD context, the term generally refers to products containing cannabidiol, hemp seed oil, or other hemp-derived ingredients in a cosmetic or skin-friendly preparation. Typical forms include creams, lotions, balms, salves, roll-ons, or body oils. Unlike oral products, topicals are not intended to be ingested through the digestive tract. Their primary area of application is the skin surface or the tissue immediately beneath it.
It is important to distinguish them from transdermal products. In dermatological and pharmaceutical literature, a clear distinction is made between topical and transdermal. Topical products primarily target a local effect on or within the skin. Transdermal systems, by contrast, are formulated so that active ingredients can overcome the skin barrier and reach systemic levels, functioning similarly to an internally acting drug. This distinction is crucial because many terms are used loosely in the market. Not every product applied to the skin is automatically intended for systemic absorption.
Precisely for this reason, the sweeping statement that "topicals only act locally" is somewhat oversimplified. This is generally true for standard cosmetic topicals. However, research shows that cannabinoids can, in principle, be skin-permeable and that the formulation, delivery system, pH level, and excipients significantly influence penetration. For Cannaseuse, the clearest definition is therefore: Topicals are generally designed for local skin application, whereas transdermal systems are specifically optimized for systemic absorption.
CBD and hemp seed-based ingredients are most frequently the focus. CBD is a non-psychotropic cannabinoid active ingredient that is the subject of much discussion in cosmetic dermatology. Reviews from 2024 and 2025 describe an interesting preclinical profile for CBD with antioxidant, anti-inflammatory, moisturizing, and sebum-regulating properties. At the same time, these same review articles emphasize that clinical evidence is currently still limited and many of the benefit claims prevalent on the market go beyond what is currently well-substantiated.
Alongside this, hemp seed oil plays an important role. It is not a CBD extract, but a fixed oil from the seeds of Cannabis sativa. In the EU cosmetic database CosIng, Cannabis Sativa Seed Oil is listed as a cosmetic ingredient. Hemp seed oil is primarily valued for its fatty acid profile and skin-nourishing properties, which is why it frequently appears in creams, facial care, body butter, or lip care products. For many topicals, it serves as the base oil or a nourishing secondary ingredient, even if the product also contains CBD.
In addition, there are classic cosmetic co-active ingredients such as shea butter, squalane, ceramides, aloe vera, panthenol, menthol, or essential oils. Especially in muscle or sports balms, cannabinoids are often not the sole contributors to the noticeable skin sensation; rather, it is the entire formulation. A "CBD topical" is therefore almost never a pure cannabinoid carrier, but always a comprehensive cosmetic system consisting of active ingredients, a lipid phase, emulsifiers, and skin feel. Anyone wanting to understand the category precisely should therefore not just look at the buzzword CBD, but at the entire INCI logic of the product.
The skin possesses its own endocannabinoid-related regulatory system. Literature clearly describes that skin cells, hair follicles, immune cells, and other skin structures exhibit cannabinoid receptors and related signaling pathways. This is exactly why the skin is considered a relevant target organ for cannabinoid-based formulations. Reviews on cosmetic dermatology and hemp in skin applications emphasize that CBD can interact with skin signaling pathways involved in inflammation processes, barrier stability, sebum production, and itching.
At the same time, one should not overstate the level of effect. Much of what is written about CBD topicals comes from cell models, animal models, or small exploratory human studies. This means there are good scientific reasons why CBD is interesting in skincare, but there is not yet a stable foundation for blanket health claims. A literature review published in 2024 states this very clearly: the available in vitro and in vivo data point to antioxidant, anti-inflammatory, moisturizing, anti-acne, and anti-aging potential, but at the same time, there is a clear need for further clinical and pharmacokinetic studies.
In practice, this means: topicals are particularly strong where local skincare, comfort, barrier support, and cosmetic routines are the focus. They are interesting for dry skin, sensitive skin, sebum-prone skin, body areas requiring care, or regeneration-oriented applications after physical exertion. However, they should not be communicated automatically as if they were approved pharmaceuticals. It is precisely this dividing line that is central to high-quality Cannaseuse texts.
A large part of the market positions topicals in the areas of muscle care, self-care, and regeneration. This is understandable because balms, sports lotions, or roll-ons work very intuitively as local applications. Medically, however, one should distinguish clearly: a cooling or warming skin sensation often results primarily from substances like menthol, camphor, or similar cosmetic additives. CBD can be part of the product, but it is not automatically the only or central reason for the subjective application experience.
When it comes to skin pathologies or wound contexts, the literature is cautiously optimistic. A systematic review from 2024 on cannabinoids in wound care saw promising preclinical and initial clinical indications but also emphasized the still-heterogeneous data situation. Newer reviews on dermatology and cosmetics are similarly reserved: cannabinoid topicals are scientifically interesting, but not yet an area with comprehensive, robust clinical backing for every advertised use.
For standard CBD topicals, the practical answer is: they are not designed for an intoxicating effect. CBD itself is not psychotropic. At the same time, one should remain precise here as well: whether a product could act psychoactively depends not only on the type of product but also on its composition, THC content, formulation, and penetration. For cosmetics, therefore, purity and regulatory classification are decisive.
Precisely for this reason, the current EU safety assessment is important. The European Commission's Scientific Committee on Consumer Safety (SCCS) published a scientific opinion on CBD in cosmetic products on November 19, 2025. In it, the SCCS concluded that CBD is considered safe in dermal and oral cosmetic products up to 0.19%; for THC impurities, a safety value of up to 0.00025% was stated. This assessment is more important for the cosmetics sector than simplified social media formulas like "everything under 0.2% THC is fine."
Status: March 23, 2026. For topicals, it is crucial that the cosmetics sector is treated legally differently than food. In its FAQ as of April 2025, the BVL (Federal Office of Consumer Protection and Food Safety) states that it is not aware of any case in which CBD would be marketable in food or food supplements. However, this strict classification does not automatically apply to cosmetic products, as cosmetics follow their own legal framework in the EU. It is exactly this distinction that is often confused in the market.
For cosmetics, the EU Cosmetics Regulation is authoritative, supplemented by CosIng and safety assessments by the SCCS. Cannabis Sativa Seed Oil is listed as a cosmetic ingredient in CosIng. Furthermore—as described above—the SCCS published a specific safety opinion on CBD in cosmetic products in November 2025. This does not mean that just any "cannabis topical" is automatically legal or free from scrutiny, but it clearly shows: the cosmetics sector is regulatorily independent and must not be conflated with novel food issues regarding CBD food products.
Equally important is the aspect of advertising. In Germany and the EU, cosmetics may not be marketed with disease-related health claims if they are not medicinal products. Especially with CBD topicals, a common mistake is therefore to present cosmetic skincare products linguistically as if they were medical therapeutics. For a serious Cannaseuse text, a clean line is decisive here: topicals can be described as skin-nourishing, barrier-supporting, soothing, or regeneration-oriented, but not indiscriminately as treatments for serious illnesses.
A good topical is not identified first by the word "CBD," but by a coherent overall formulation. Decisive factors are a comprehensible INCI list, high-quality carrier oils, stable emulsions, sensible accompanying ingredients, and a clear product category. Especially for sensitive or reactive skin, it is worth looking at fragrances, menthol, essential oils, and preservative systems. A "mild CBD balm" can be more sensible for sensitive skin than a heavily perfumed active balm with irritating additives.
Equally important is transparency regarding the raw material source. Hemp seed oil, CBD isolate, and hemp extracts are not the same thing. For a curated selection like at Cannaseuse, precisely this differentiation is crucial because it creates product understanding: topicals are not simply "cannabis in cream form," but a category in which raw material quality, cosmetic formulation, and regulatory cleanliness count together.
Topicals are externally applicable products such as creams, balms, salves, lotions, or oils that contain cannabinoid or hemp-based ingredients and are applied directly to the skin. They belong to local skincare and wellness applications, not to classic oral ingestion.
Topical products are intended for a local effect on or in the skin. Transdermal systems are formulated so that active ingredients penetrate the skin barrier and can reach systemic levels. This distinction is technically central and is often used loosely in the market.
CBD is not psychotropic, and classic CBD topicals are not designed for an intoxicating effect. For cosmetic products, purity, trace THC, and regulatory thresholds play a major role; the SCCS considers THC impurities in cosmetic products up to 0.00025% to be safe.
Cosmetic products are legally classified differently than food. While the BVL did not see CBD food and food supplements as marketable in 2025, EU cosmetics regulations apply to cosmetics; hemp seed oil is listed in CosIng, and a safety assessment by the SCCS for cosmetic applications of CBD has been available since November 2025.
They are most frequently used for dry or sensitive skin, cosmetic regeneration, sebum-prone skin, sports and wellness routines, and barrier-supporting care. Research sees interesting potential here but continues to emphasize the limited clinical data situation.
Topicals are one of the most interesting hemp and CBD categories of all because they bring together skincare, cannabinoid knowledge, and modern product culture. Their greatest value does not lie in exaggerated health claims, but in local, everyday application: as nourishing, barrier-supporting, and cosmetically exciting formulations with hemp seed oil, CBD, and carefully selected secondary ingredients. This is exactly where they unfold their potential most credibly.